BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6256337)

  • 1. Subcellular action of Neocarzinostatin. Intracellular incorporation, DNA breakdown and cytotoxicity.
    Takeshita J; Maeda H; Koike K
    J Biochem; 1980 Oct; 88(4):1071-80. PubMed ID: 6256337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic effect of neocarzinostatin on human lymphoid cells.
    Maeda H; Matsumoto M
    Tohoku J Exp Med; 1979 Aug; 128(4):313-23. PubMed ID: 225845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity and reduced inhibition of DNA synthesis in ataxia telangiectasia lymphoblasts treated with low levels of neocarzinostatin.
    Babilon RW; Soprano KJ; Henderson EE
    Mutat Res; 1985 Jul; 146(1):79-87. PubMed ID: 3158810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repair of neocarzinostatin-induced deoxyribonucleic acid damage in human lymphoblastoid cells: possible involvement of apurinic/apyrimidinic sites as intermediates.
    Tatsumi K; Bose KK; Ayres K; Strauss BS
    Biochemistry; 1980 Oct; 19(21):4767-72. PubMed ID: 6252959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neocarzinostatin-induced DNA strand scission and subsequent cell cycle traverse in HeLa S3 cells.
    Berry DE; Collins JM
    Cancer Res; 1980 Jul; 40(7):2405-10. PubMed ID: 6446380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of neocarzinostatin-induced strand scission on the template activity of DNA for DNA polymerase I.
    Kappen LS; Goldberg IH
    Biochemistry; 1977 Feb; 16(3):479-85. PubMed ID: 138435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro mode of action, pharmacokinetics, and organ specificity of poly (maleic acid-styrene)-conjugated neocarzinostatin, SMANCS.
    Takeshita J; Maeda H; Kanamaru R
    Gan; 1982 Apr; 73(2):278-84. PubMed ID: 6214446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive effects of bleomycin and neocarzinostatin on degradation of DNA, inhibition of DNA polymerase beta, and cell growth.
    Müller WE; Maidhof A; Arendes J; Geurtsen W; Zahn RK; Schmidseder R
    Cancer Res; 1979 Sep; 39(9):3768-73. PubMed ID: 89904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitination capabilities in response to neocarzinostatin and H(2)O(2) stress in cell lines from patients with ataxia-telangiectasia.
    Taylor A; Shang F; Nowell T; Galanty Y; Shiloh Y
    Oncogene; 2002 Jun; 21(28):4363-73. PubMed ID: 12080467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of bleomycin, neocarzinostatin, and auromomycin cleavage of cell-free and intracellular simian virus 40 DNA and chromatin.
    Grimwade JE; Beerman TA
    Mol Pharmacol; 1986 Oct; 30(4):358-63. PubMed ID: 2429169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of chromophore and apo-protein in neocarzinostatin action.
    Kappen LS; Napier MA; Goldberg IH
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):1970-4. PubMed ID: 6445563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction and repair of DNA damage in normal and ataxia-telangiectasia skin fibroblasts treated with neocarzinostatin.
    Shiloh Y; van der Schans GP; Lohman PH; Becker Y
    Carcinogenesis; 1983; 4(7):917-21. PubMed ID: 6223717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage and repair in relation to cell killing in neocarzinostatin-treated HeLa cells.
    Hatayama T; Goldberg IH
    Biochim Biophys Acta; 1979 Jun; 563(1):59-71. PubMed ID: 159073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unscheduled DNA synthesis in human lymphocytes treated with neocarzinostatin.
    Tatsumi K; Sakane T; Sawada H; Shirakawa S; Nakamura T
    Gan; 1975 Aug; 66(4):441-4. PubMed ID: 126891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of DNA polymerase beta activity in permeabilized mouse P815 mast cells after neocarzinostatin treatment.
    Geurtsen W; Zahn RK; Maidhof A; Müller WE
    Gan; 1981 Apr; 72(2):259-63. PubMed ID: 6456962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphonoacetic acid: inhibition of transformation of human cord blood lymphocytes by Epstein-Barr virus.
    Manor D; Margalith M
    Cancer Biochem Biophys; 1979; 3(4):157-62. PubMed ID: 233303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of DNA degradation induced by neocarzinostatin in Bacillus subtilis.
    Ohtsuki K; Ishida N
    J Antibiot (Tokyo); 1975 Mar; 28(3):229-36. PubMed ID: 123897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-radiolysis study of the reductive activation of neocarzinostatin by the carboxyl radical.
    Favaudon V
    Biochimie; 1983; 65(11-12):593-607. PubMed ID: 6231960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin fibroblasts from patients with the genetic disorder hereditary hemorrhagic telangiectasia compared with ataxia-telangiectasia fibroblasts in their response to the radiomimetic drug neocarzinostatin.
    Becker Y; Tabor E
    Isr J Med Sci; 1989 Feb; 25(2):81-6. PubMed ID: 2522915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of succinyl neocarzinostatin in vivo.
    Maeda H; Ichimura H; Satoh H; Ohtsuki K
    J Antibiot (Tokyo); 1978 May; 31(5):468-72. PubMed ID: 149781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.